02.03.2020 23:48:00
|
Gilead Sciences, Inc. -- Moody's: Gilead's acquisition of Forty Seven reduces cash levels but expands oncology focus
Announcement: Moody's: Gilead's acquisition of Forty Seven reduces cash levels but expands oncology focusVollständigen Artikel bei Moodys lesen